BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Canada/Eastern
BEGIN:DAYLIGHT
DTSTART:20210314T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20211107T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20211103T153520Z
UID:3301702F-3AE4-4188-9713-2721741BF9B5
DTSTART;TZID=Canada/Eastern:20211103T100000
DTEND;TZID=Canada/Eastern:20211103T110000
DESCRIPTION:In the last decade\, there has been an increased interest in pr
 oposing\, investigating\, manufacturing - and therefore in regulating - no
 vel medical approaches and technologies complementary or even competitive 
 to the traditional pharmacological and surgical ones that are aimed at rec
 overing lost body functionalities (e.g.\, limb movement) or at relieving m
 edical conditions derived from compromised organ functions. The goal of bi
 oelectronic medicine is the use of smart devices to ensure efficient\, saf
 e and personalized medical treatment through the precise and therapeutic d
 elivery of physical agents (electromagnetic fields\, heat\, acoustic waves
 \, etc.) to the nervous system. In silico modelling is widely used to faci
 litate the development and the optimization of these technologies (e.g.\, 
 electroceuticals) and allows mechanistic investigations\, the identificati
 on and and estimation of treatment-related quantities of interest (QoIs) (
 e.g. specific dose and dose metrics)\, the investigation of safety and per
 formance related aspects (e.g. dose uncertainty) as well as personalized t
 reatment. In this talk the challenges faced by bioelectronic medicine will
  be discussed\, and the in silico methods developed to facilitate the engi
 neering of multiple neurostimulation-related technologies (including elect
 roceuticals\, spinal cord and deep brain stimulators\, as well as non-inva
 sive brain stimulation devices) are discussed.\n\nSpeaker(s): Dr. Antonino
  Cassara\, \n\nMontreal\, Quebec\, Canada\, Virtual: https://events.vtools
 .ieee.org/m/287023
LOCATION:Montreal\, Quebec\, Canada\, Virtual: https://events.vtools.ieee.o
 rg/m/287023
ORGANIZER:lena.kranold@mail.mcgill.ca
SEQUENCE:6
SUMMARY:In Silico Modelling in Support of Neurostimulation: Device Developm
 ent\, Treatment Optimization and Mechanistic Investigations
URL;VALUE=URI:https://events.vtools.ieee.org/m/287023
X-ALT-DESC:Description: <br /><p>In the last decade\, there has been an inc
 reased interest in proposing\, investigating\, manufacturing - and therefo
 re in regulating - novel medical approaches and technologies complementary
  or even competitive to the traditional pharmacological and surgical ones 
 that are aimed at recovering lost body functionalities (e.g.\, limb moveme
 nt) or at relieving medical conditions derived from compromised organ func
 tions. The goal of bioelectronic medicine is the use of smart devices to e
 nsure efficient\, safe and personalized medical treatment through the prec
 ise and therapeutic delivery of physical agents (electromagnetic fields\, 
 heat\, acoustic waves\, etc.) to the nervous system. In silico modelling i
 s widely used to facilitate the development and the optimization of these 
 technologies (e.g.\, electroceuticals) and allows mechanistic investigatio
 ns\, the identification and and estimation of treatment-related quantities
  of interest (QoIs) (e.g. specific dose and dose metrics)\, the investigat
 ion of safety and performance related aspects (e.g. dose uncertainty) as w
 ell as personalized treatment. In this talk the challenges faced by bioele
 ctronic medicine will be discussed\, and the in silico methods developed t
 o facilitate the engineering of multiple neurostimulation-related technolo
 gies (including electroceuticals\, spinal cord and deep brain stimulators\
 , as well as non-invasive brain stimulation devices) are discussed.</p>
END:VEVENT
END:VCALENDAR